AJP - Lung Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 289: L1123-L1130, 2005. First published August 5, 2005; doi:10.1152/ajplung.00049.2005
1040-0605/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/6/L1123    most recent
00049.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farmen, S. L.
Right arrow Articles by Welsh, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farmen, S. L.
Right arrow Articles by Welsh, M. J.

Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl transport and overexpression can generate basolateral CFTR

Sara L. Farmen,1 Philip H. Karp,2,3 Philip Ng,4 Donna J. Palmer,4 David R. Koehler,5 Jim Hu,5 Arthur L. Beaudet,4 Joseph Zabner,2 and Michael J. Welsh1,2,3

Departments of 1Physiology and Biophysics and 2Internal Medicine, 3Howard Hughes Medical Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242; 4Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030; and 5Lung Biology Research Program, Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada

Submitted 25 January 2005 ; accepted in final form 28 July 2005

Gene transfer of CFTR cDNA to airway epithelia is a promising approach to treat cystic fibrosis (CF). Most gene transfer vectors use strong viral promoters even though the endogenous CFTR promoter is very weak. To learn whether expressing CFTR at a low level in a fraction of cells would correct Cl transport, we mixed freshly isolated wild-type and CF airway epithelial cells in varying proportions and generated differentiated epithelia. Epithelia with ~20% wild-type cells generated ~70% the transepithelial Cl current of epithelia containing 100% wild-type cells. These data were nearly identical to those previously obtained with CFTR expressed under control of a strong promoter in a CF epithelial cell line. We also tested high level CFTR expression using the very strong cytomegalovirus (CMV) promoter as well as the cytokeratin-18 (K18) promoter. In differentiated airway epithelia, the CMV promoter generated 50-fold more transgene expression than the K18 promoter, but the K18 promoter generated more transepithelial Cl current at high vector doses. Using functional studies, we found that with marked overexpression, some CFTR channels were present in the basolateral membrane where they shunted Cl flow, thereby reducing net transepithelial Cl transport. These results suggest that very little CFTR is required in a fraction of CF epithelial cells to complement Cl transport because transepithelial Cl flow is limited at the basolateral membrane. Thus they suggest a broad leeway in promoter strength for correcting the CF gene transfer, although at very high expression levels CFTR may be mislocalized to the basolateral membrane.

cystic fibrosis; gene therapy; promoter; cytomegalovirus; cytokeratin-18



Address for reprint requests and other correspondence: M. J. Welsh, Howard Hughes Medical Inst., Roy J. and Lucille A. Carver College of Medicine, Univ. of Iowa, 500 EMRB, Iowa City, IA 52242 (e-mail: michael-welsh{at}uiowa.edu)




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
R. Robert, G. W. Carlile, C. Pavel, N. Liu, S. M. Anjos, J. Liao, Y. Luo, D. Zhang, D. Y. Thomas, and J. W. Hanrahan
Structural Analog of Sildenafil Identified as a Novel Corrector of the F508del-CFTR Trafficking Defect
Mol. Pharmacol., February 1, 2008; 73(2): 478 - 489.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
O. Granio, C. Norez, K. J. D. Ashbourne Excoffon, P. H. Karp, M. Lusky, F. Becq, P. Boulanger, J. Zabner, and S.-S. Hong
Cellular Localization and Activity of Ad-Delivered GFP-CFTR in Airway Epithelial and Tracheal Cells
Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 631 - 639.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. M. Bruscia, E. C. Ziegler, J. E. Price, S. Weiner, M. E. Egan, and D. S. Krause
Engraftment of Donor-Derived Epithelial Cells in Multiple Organs Following Bone Marrow Transplantation into Newborn Mice
Stem Cells, October 1, 2006; 24(10): 2299 - 2308.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.